Daiichi Sankyo and Merck & Co. to co-develop and commercialize three of Daiichi Sankyo’s DXd antibody-drug conjugate (ADC) candidates worldwide except for Japan where...
UK-based Astex Pharmaceuticals, specialized in the discovery and development of novel small molecule therapeutics for oncology and diseases of the central nervous system...
A move by US drugmaker Merck & Co. to have Bayer assume all liability for lawsuits alleging that the talc-based Dr. Scholl's foot powder causes cancer has failed, at...
Austrian biotech Proxygen has announced a multi-year collaboration and license agreement with US drugmaker Merck & Co to identify and develop molecular glue degraders...
US drugmaker Merck & Co. plans to add 100 new jobs as part of an expansion project at its site in Carlow, Ireland, which opened in 2008 as the company’s first vaccines...
Pfizer will invest $120 million at its plant in Kalamazoo, Michigan, to support US production of its Paxlovid (nirmatrelvir) oral antiviral treatment for Covid-19. The...
The US Food and Drug Administration (FDA) has greenlit GSK’s Priorix-branded GSK’s mumps and rubella vaccine (MMR) for people 12 months and older. It is only the second...
US pharma group Merck & Co is collaborating with Curve Therapeutics, a privately-held UK biotech that has developed a proprietary functional drug discovery platform...
